SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000897101-19-000289
Filing Date
2019-03-26
Accepted
2019-03-26 15:24:01
Documents
1
Group Members
IBS TURNAROUND FUND, L.P., THE IBS TURNAROUND FUND (QP) (A LTD PARTNERSHIP), THE IBS OPPORTUNITY FUND, LTD., DAVID A. TAFT

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G ibs190662_sc13ga.htm SC 13G/A 220344
  Complete submission text file 0000897101-19-000289.txt   221944
Mailing Address ONE INTERNATIONAL PLACE 31ST FLOOR BOSTON MA 02110
Business Address ONE INTERNATIONAL PLACE 31ST FLOOR BOSTON MA 02110 (617) 310-5160
IBS CAPITAL LLC (Filed by) CIK: 0001414860 (see all company filings)

IRS No.: 261094312
Type: SC 13G/A

Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-521-3390
AgeX Therapeutics, Inc. (Subject) CIK: 0001708599 (see all company filings)

IRS No.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90737 | Film No.: 19705185
SIC: 2834 Pharmaceutical Preparations